ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,133Medicare Part D Prescriptions Filled, Including Refills

Rank: 20 out of 36

$423K Total Retail Price of All Prescriptions

Rank: 19 out of 36

279 Patients Receiving at Least One Drug in Part D
100%Patients 65 Years and Older
0% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 279 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 279 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,132 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 401 401 1 4
NAMENDA 254 254 2 13
LISINOPRIL 219 219 3 3
DONEPEZIL HCL 212 212 4 12
SIMVASTATIN 207 207 5 2
AMLODIPINE BESYLATE 190 190 6 1
FUROSEMIDE 180 180 7 5
OMEPRAZOLE 171 171 8 6
GABAPENTIN 141 141 9 10
WARFARIN SODIUM 127 127 10 17
ZOLPIDEM TARTRATE 119 119 11 24
METOPROLOL SUCCINATE 116 116 12 18
CITALOPRAM HBR 113 113 13 16
ATENOLOL 97 97 14 27
MIRTAZAPINE 95 95 15 28
EXELON 92 92 16 56
HYDROCODONE-ACETAMINOPHEN 90 90 S3 17 7
SERTRALINE HCL 87 87 18 19
POTASSIUM CHLORIDE 85 85 19 15
TAMSULOSIN HCL 84 84 20 41
HYDROCHLOROTHIAZIDE 82 82 21 9
TRAMADOL HCL 80 80 22 14
VENLAFAXINE HCL ER 80 80 22 87
HYDRALAZINE HCL 79 79 24 29
METOPROLOL TARTRATE 75 75 25 8
DIOVAN 74 74 26 40
KLOR-CON M20 67 67 27 32
ALENDRONATE SODIUM 65 65 28 34
MELOXICAM 65 65 28 53
FENTANYL 64 64 S2 30 111
QUETIAPINE FUMARATE 62 62 31 37
ATORVASTATIN CALCIUM 60 60 32 22
RISPERIDONE 59 59 33 31
LOSARTAN POTASSIUM 58 58 34 23
CIPROFLOXACIN HCL 58 58 34 60
FAMOTIDINE 57 57 36 30
CARBIDOPA-LEVODOPA 55 55 37 73
LEVOFLOXACIN 54 54 38 89
CLOPIDOGREL 52 52 39 33
CARVEDILOL 50 50 40 20
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.